Dabur Pharma receives USFDA approval for generic Irinotecan

Dabur Pharma receives USFDA approval for generic Irinotecan
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney SME Special
moneycontrol.com

Home » News » Business

Nov 01, 2007, 04.03 PM | Source: Moneycontrol.com

Dabur Pharma receives USFDA approval for generic Irinotecan

Dabur Pharma receives USFDA approval for generic Irinotecan

Like this story, share it with millions of investors on M3

Dabur Pharma receives USFDA approval for generic Irinotecan

Dabur Pharma receives USFDA approval for generic Irinotecan

Post Your Comments

Share Cancel

Dabur Pharma Ltd. (NSE: DABURPHARM, BSE: 532545), India’s leading oncology player, today announced that the US Food and Drug Administration (USFDA) has granted tentative approval to the Company’s Abbreviated New Drug Application (ANDA) to market it’s generic version of Pfizer’s Camptosar (Irinotecan Hydrochloride) Injection 40mg and 100mg.

 

Irinotecan, which had sales of over US$ 500 million in the US (IMS - MAT 03/07), is indicated as a component of first line therapy in combination with 5- fluorouracil and leucovorin for the patients with metastatic carcinoma of the colon or rectum. Irinotecan is also indicated for the patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil- based therapy.

 

The Company said that it expects to begin marketing the drug in US upon expiry of the patent in February 2008.

 

Speaking on the occasion, Ajay Kumar Vij, CEO, Dabur Pharma said that “this marks a major milestone for Dabur Pharma, which is vertically integrated in the product and is already one of the largest producers of Irinotecan API (Active Pharmaceutical Ingredient) in the world.  The Company is one of the most cost effective producers of Irinotecan in the world and the approval & subsequent launch will provide a quantum jump to our aggressive growth plans”.

Sourced From : Imprimis Life PR Pvt Ltd

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Dabur Pharma receives USFDA approval for generic Irinotecan

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login